Clinical Trial Update: Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old [Phase 2]

View source ↗

Summary

Phase 2 clinical pharmacology update for CHF 1535 50/6 ug Next DPI in children aged 5-11 with asthma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma in Children

Drugs mentioned

• CHF 1535 50/6 ug Next DPI

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma in Children | Phase 2 | Status: COMPLETED